NCT02011581

Brief Summary

The purpose of this research study is to learn more about how our body produces sugar, breaks down fat for fuel, and makes insulin (the major hormone that controls the production of blood sugar and fat breakdown) during a 24-hour day and how body fat and muscle are involved in these processes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2011

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2011

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

December 9, 2013

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 13, 2013

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2014

Completed
Last Updated

April 30, 2015

Status Verified

April 1, 2015

Enrollment Period

2.2 years

First QC Date

December 9, 2013

Last Update Submit

April 28, 2015

Conditions

Keywords

Overweight

Outcome Measures

Primary Outcomes (2)

  • Determine postprandial beta-cell function (insulin secretion) after ingesting breakfast and dinner meals.

    Postprandial pancreatic beta-cell function will be evaluated by using a mixed meal labelled with stable isotope tracers, in conjunction with stable isotope tracer infusion. Metabolic outcomes from the breakfast meal will be compared with values obtained after dinner.

    24 hours

  • Determine postprandial hepatic insulin sensitivity (suppression of endogenous glucose production) after ingesting breakfast and dinner meals.

    Postprandial pancreatic hepatic insulin sensitivity will be evaluated by using a mixed meal labelled with stable isotope tracers, in conjunction with stable isotope tracer infusion. Metabolic outcomes from the breakfast meal will be compared with values obtained after dinner.

    24 hours

Secondary Outcomes (3)

  • Determine whether there is diurnal variability in muscle insulin signaling

    24 hours

  • Determine whether there is diurnal variability in adipose tissue and systemic inflammation.

    24 hours

  • Determine whether there is diurnal variability in NAMPT-mediated NAD+ biosynthesis and SIRT1.

    24 hours

Eligibility Criteria

Age18 Years - 55 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study population will consist of female subjects of all races and ethnic groups. Participants will be recruited by reviewing our database of research subjects containing thousands of research study volunteers and by St. Louis metro area postings.

You may qualify if:

  • Females
  • years old
  • BMI between 25.0-29.9 kg/m2
  • Must be sedentary (regular exercise \<1hour/week or \<2 times/week

You may not qualify if:

  • Regular exercise (\>1hour/week or \>2 times/week)
  • Diabetes
  • Severe organ dysfunction
  • Smokers
  • Severe hypertriglyceridemia (\>300 mg/dl)
  • Medications that may alter the results of the study
  • Pregnant
  • Breastfeeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Location

Related Publications (1)

  • Yamaguchi S, Moseley AC, Almeda-Valdes P, Stromsdorfer KL, Franczyk MP, Okunade AL, Patterson BW, Klein S, Yoshino J. Diurnal Variation in PDK4 Expression Is Associated With Plasma Free Fatty Acid Availability in People. J Clin Endocrinol Metab. 2018 Mar 1;103(3):1068-1076. doi: 10.1210/jc.2017-02230.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood samples, adipose tissue samples and muscle samples

MeSH Terms

Conditions

Overweight

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Samuel Klein, M.D.

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 9, 2013

First Posted

December 13, 2013

Study Start

October 1, 2011

Primary Completion

December 1, 2013

Study Completion

March 1, 2014

Last Updated

April 30, 2015

Record last verified: 2015-04

Locations